Cabaletta Bio Inc (CABA) Is Not Likely To Be The Same Tomorrow

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

Cabaletta Bio Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Cabaletta Bio Inc is $1.09B. A total of 2.49 million shares were traded on the day, compared to an average of 1.28M shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, CABA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 6 BUYs and 10 SELLs from insiders. Insiders purchased 77,000 shares during that period but sold 77,000.

In the most recent transaction, Binder Gwendolyn sold 11,000 shares of CABA for 19.59 per share on Jan 19. After the transaction, the insider now owns 20,000 company shares. In a previous transaction on Dec 19, Binder Gwendolyn sold 11,000 shares at 21.89 per share. CABA shares that the insider owns now total 20,000.

Among the insiders who sold shares, Binder Gwendolyn disposed of 11,000 shares on Nov 20 at a per-share price of $17.82. This resulted in the insider holding 20,000 shares of CABA after the transaction. In another insider transaction, Binder Gwendolyn sold 11,000 shares at $13.36 per share on Oct 19. Company shares held by the insider now total 20,000.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for CABA in the last 3 months, the mean price target is $32.44 with high estimates of $50.00 and low estimates of $25.00. In terms of 52-week highs and lows, CABA has a high of $24.62 and a low of $5.88.

As of this writing, CABA has an earnings estimate of -$0.39 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.33 per share and a lower estimate of -$0.45. The company reported an EPS of -$0.37 in the last quarter, which was 15.90% higher than expectations of -$0.44.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CABA’s latest balance sheet shows that the firm has $122.22M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $8.38M in liabilities at the time. Its Book Value Per Share was $3.86, while its Total Shareholder’s Equity was $117.96M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CABA is Buy with a score of 5.00.

Most Popular

Related Posts